Proteomic analysis of p38α mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblasts

被引:22
作者
Alfonso, Patricia [1 ]
Dolado, Ignacio [2 ]
Swat, Aneta [2 ]
Nunez, Antonio [1 ]
Cuadrado, Ana [2 ]
Nebreda, Angel R. [2 ]
Ignacio Casal, J. [1 ]
机构
[1] Ctr Nacl Invest Oncol, Biotechnol Program, Prot Technol Unit, Madrid 28029, Spain
[2] Ctr Nacl Invest Oncol, Signaling & Cell Cycle Grp, Mol Oncol Program, Madrid 28029, Spain
关键词
2-D-DIGE; MALDI-TOF; Membrane fractions; p38; MAPK; Ras; Transformation;
D O I
10.1002/pmic.200500350
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Oncogenic Ras signaling has been long known to play an important role in tumorigenesis and human cancer. In this report, we have used the sensitive 2-D-DIGE coupled to MS for the identification of proteins differentially expressed at the cell membrane level between oncogenic H-RasV12-transformed wild-type and p38 alpha-deficient mouse embryo fibroblasts (MEFs). Following trifluoroethanol solubilization, 76 proteins were found to be differentially regulated. After PMF, 63 spots containing 42 different proteins were unequivocally identified by MALDI-TOF MS coupled with database interrogation. As expected, many of them were membrane proteins. Six proteins were selected for further validation studies based on their potential functional link with malignant transformation and signal transduction. These were prohibitin (PHB), protein disulfide isomerase 3 (PDIA3), focal adhesion kinase 2 (FAK2), c-GMP dependent protein kinase 2 (KGP2), NADH-ubiquinone oxidoreductase 30 kDa subunit (NUGM) and translationally controlled tumor protein (TCTP). All these proteins were up-regulated in the membranes of H-RasV12-transformed p38 alpha-/-cells, except for prohibitin, which was down-regulated. An excellent correlation was found between DIGE results and Western blot studies, indicating the reliability of the 2-D-DIGE analysis. The available evidence about the putative function of the identified proteins supports the emerging role of p38 alpha as a negative regulator of tumorigenesis. Further studies are in progress to elucidate the implications of these findings in the regulation of H-Ras-induced transformation by p38 alpha signaling.
引用
收藏
页码:S262 / S271
页数:10
相关论文
共 37 条
[1]   Identification of cellular proteins modified in response to African swine fever virus infection by proteomics [J].
Alfonso, P ;
Rivera, J ;
Hernáez, B ;
Alonso, C ;
Escribano, JM .
PROTEOMICS, 2004, 4 (07) :2037-2046
[2]   The translationally controlled tumour protein (TCTP) [J].
Bommer, UA ;
Thiele, BJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (03) :379-385
[3]  
BOS JL, 1989, CANCER RES, V49, P4682
[4]   Regulation of fibronectin matrix assembly by activated Ras in transformed cells [J].
Brenner, KA ;
Corbett, SA ;
Schwarzbauer, JE .
ONCOGENE, 2000, 19 (28) :3156-3163
[5]   p38 MAP kinase's emerging role as a tumor suppressor [J].
Bulavin, DV ;
Fornace, AJ .
ADVANCES IN CANCER RESEARCH, VOL 92, 2004, 92 :95-118
[6]   Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity [J].
Bulavin, DV ;
Demidov, ON ;
Saito, S ;
Kauraniemi, P ;
Phillips, C ;
Amundson, SA ;
Ambrosino, C ;
Sauter, G ;
Nebreda, AR ;
Anderson, CW ;
Kallioniemi, A ;
Fornace, AJ ;
Appella, E .
NATURE GENETICS, 2002, 31 (02) :210-215
[7]  
Celli CM, 2003, CANCER RES, V63, P6016
[8]   Exploitation of specific properties of trifluoroethanol for extraction and separation of membrane proteins [J].
Deshusses, JMP ;
Burgess, JA ;
Scherl, A ;
Wenger, Y ;
Walter, N ;
Converset, V ;
Paesano, S ;
Corthals, GL ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2003, 3 (08) :1418-1424
[9]   Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth [J].
Engelman, JA ;
Wykoff, CC ;
Yasuhara, S ;
Song, KS ;
Okamoto, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16374-16381
[10]   P38α MAPK is required for contact inhibition [J].
Faust, D ;
Dolado, I ;
Cuadrado, A ;
Oesch, F ;
Weiss, C ;
Nebreda, AR ;
Dietrich, C .
ONCOGENE, 2005, 24 (53) :7941-7945